Obstructive sleep apnoea (OSA), characterized by recurrent periods of upper airway
obstruction and intermittent hypoxaemia, is prevalent in patients with cardiovascular disease …

OSA is a chronic treatable sleep disorder and a frequent comorbidity in patients with type 2
diabetes. Cardinal features of OSA, including intermittent hypoxemia and sleep …

Sleep disorders are linked to development of type 2 diabetes and increase the risk of
developing diabetes complications. Treating sleep disorders might therefore play an …

Summary Sleep disturbances [short (< 6 h) and long (> 8 h) sleeping time, insomnia
(initiating or maintaining sleep), obstructive sleep apnea (OSA) and abnormal sleep timing] …

Obstructive sleep apnea (OSA) is a highly prevalent disease, and is traditionally associated
with increased cardiovascular risk. The role of comorbidities in OSA patients has emerged …

The anatomy and physiology of the microcirculation in human skin are complex. Normal
cutaneous microcirculation is organized in two parallel plexuses with capillary loops …

Cardiac autonomic neuropathy (CAN) is an often overlooked and common complication of
diabetes mellitus. CAN is associated with increased cardiovascular morbidity and mortality …

Sleep disturbances, including sleep insufficiency and sleep fragmentation, have been linked
to abnormal glucose metabolism and increased diabetes risk. Well‐controlled laboratory …

Peripheral microvascular dysfunction has been described in many physiological and
pathological conditions. Owing to its accessibility, the cutaneous microcirculation provides a …

Distal symmetric sensorimotor polyneuropathy (DSPN) is the most common neurological
manifestation in diabetes. Major risk factors of DSPN include diabetes duration …